Icon Bioscience

Sunnyvale, United States Founded: 2004 • Age: 22 yrs Acquired By EyePoint Pharmaceuticals
Online pharmacy providing prescription drugs and other health products

About Icon Bioscience

Icon Bioscience is a Healthcare company based in Sunnyvale (United States) founded in 2004, and was acquired by EyePoint Pharmaceuticals in March 2018. Online pharmacy providing prescription drugs and other health products. Icon Bioscience has raised $37.32 million across 3 funding rounds from investors including EyePoint Pharmaceuticals. Icon Bioscience offers products and services including Prescription Medications and Online Pharmacy Services. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its legal entity is My Canadian Pharmacy.

Company details

Icon Bioscience was established in 2004 in Sunnyvale, United States, operating as an online pharmacy in the healthcare sector. Medications for conditions such as erectile dysfunction, birth control, asthma, and pain relief are sourced directly from manufacturers with emphasis on quality control and proper storage. Existing prescriptions can be transferred or refilled by customers, including as guests, while a search function aids product location. Pharmacist consultations are available for inquiries.

Key Metrics

Products & Services of Icon Bioscience

Icon Bioscience offers a comprehensive portfolio of products and services, including Prescription Medications and Online Pharmacy Services.

Prescription Medications
Pharmaceuticals

Various prescription drugs are sold for conditions such as erectile dysfunction and asthma.

Online Pharmacy Services
Health Services

Services including prescription refills and transfers are offered to support customer access to medications.

Funding Insights of Icon Bioscience

Icon Bioscience has successfully raised a total of $37.32M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.32 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $37.32M
  • Total Rounds 3
  • Last Round Series B β€” $5.32M
  • First Round $17M

    (Jun 2013)

All 3 funding rounds of Icon Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2015$5.32MSeries B––
–
Aug 2013$15MSeries B––
–
Jun 2013$17MSeries A––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Icon Bioscience

Icon Bioscience has secured backing from 1 investor. Prominent investors backing the company include EyePoint Pharmaceuticals.

All
InvestorDescriptionFounded YearDomainLocation
Small molecule therapeutics for ophthalmic disorders are developed.
1987eyepointpharma.comWatertown, United States
Premium access

Investor details for Icon Bioscience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Icon Bioscience

4 dated milestones of Icon Bioscience across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Icon Bioscience is founded.
  2. Funding First funding round of $17.0M.
  3. Funding Latest funding round, Series B, of $5.3M.
  4. Exit Acquired by EyePoint Pharmaceuticals.

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as Icon Bioscience (Digital Health & Telemedicine) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
An application is provided for comparing prescription drug prices nationwide.
2011Santa Monica, California, United StatesUSD 22.21 MUSD 796.85 M1,063
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Alto Pharmacy is focused on providing convenient prescription delivery services.
2015San Francisco, California, United StatesUSD 591.64 M802
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Icon Bioscience

Premium access

Complete news archive for Icon Bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Icon Bioscience

Icon Bioscience was founded in 2004 and raised its 1st funding round 9 years after it was founded.

Icon Bioscience is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.

Icon Bioscience is a funded company, having raised a total of $37.32M across 3 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Jun 2013.

Icon Bioscience was established in 2004 in Sunnyvale, United States, operating as an online pharmacy in the healthcare sector. Medications for conditions such as erectile dysfunction, birth control, asthma, and pain relief are sourced directly from manufacturers with emphasis on quality control and proper storage. Existing prescriptions can be transferred or refilled by customers, including as guests, while a search function aids product location. Pharmacist consultations are available for inquiries.

Icon Bioscience offers Prescription Medications and Online Pharmacy Services.

Icon Bioscience has 1 investor. Key investors include EyePoint Pharmaceuticals.

Icon Bioscience operates through My Canadian Pharmacy.

Yes. Icon Bioscience was acquired by EyePoint Pharmaceuticals in March 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available